Glenn Pierce

@wfhemophilia Victor was a major force for patients and health care providers in many countries around the world. His vision will be greatly missed but the good he has done remains for all.

It is with great sadness that the WFH learned of the passing of Victor Stanley Blanchette, MD, Medical Director of the Paediatric Thrombosis and Haemostasis Program at SickKids (Toronto). Our deepest sympathies to his family members, friends & colleagues. wfh.org/article/wfh-mo…

🚨 Time's running out to submit your #BleedingDisorders research to the #WFHCongress2024! Don't miss this opportunity to showcase your work on a global stage, win prestigious awards, and connect with global experts. Deadline: Nov 15, 2023. Submit now:bit.ly/3sTJkBm 🩸

World Federation of Hemophilia (@wfhemophilia) and (@EHC_Haemophilia) statement on vaccine thrombosis thrombocytopenia. Persons with bleeding disorders not at increased risk from very rare event, should get vaccinated. Risks of COVID-19 greater ow.ly/urIU50EmxX8

Come watch the arguments, assessments and suggestions for evaluating gene therapies for hemophilia

@wfhemophilia Congratulations Steve. Well deserved!

The WFH presents this year’s International Healthcare Volunteer Award to Dr. Steve Kitchen, for his dedication in sharing knowledge on #laboratory science with healthcare professionals globally. On behalf of the #bleedingdisorders community, Thank you! wfh.org/en/about/awards

The #WFHVirtualSummit Committee understands the importance of sharing knowledge of #VWD and the Summit program reflects this. Glenn Pierce, MD, PhD, WFH Vice-President, Medical, highlights the importance of bringing awareness to VWD. Watch the video here: ow.ly/hMnh50zRnIb

The High Price of Hemophilia ashclinicalnews.org/spotlight/feat… via @ASH Clinical News

The hemophilia gene therapy race faces a critical year in 2020 biopharmadive.com/news/hemophili… via @BioPharmaDive

@thehill This picture says it all

"This photo could be a Pelosi campaign poster — the sole woman in the room, literally standing up to the President. Why he thinks this makes her look bad is a mystery.” hill.cm/peQeoSY

@ProfMakris This appears to support the Iorio-Stonebraker Ann Int Med data based upon complete reporting in 6 countries

A study from Indiana has found that the prevalence of hemophilia is 45% higher than previously reported in the USA. Supports increasing evidence that the prevalence of haemophilia at birth is higher than previously thought. tiny.cc/t7meez #hemophilia #haemophilia

assuming specific activity of the transgene protein is same as pd or recombinant. Ag levels are not the solution unless specific activity is previously validated.

@Brianhaemophil1 @NHF_Hemophilia @HaemophiliaIRL This recombinant FX manufactured to treat hemA and hemB dogs who have inhibitors. Effective replacement to manage dogs

Canine Gene Therapy vectors for FVIII,FIX and FX used in dogs with haemophilia in University of North Carolina at Chapel Hill @NHF_Hemophilia @HaemophiliaIRL

The WFH WBDR has reached another milestone – over 2,500 patients! We are well on our way to our goal of enrolling 10,000 patients #patientvoice.The WFH would like to thank everyone involved for helping us to grow the WBDR #bleedingdisorders #hemophilia wfh.org/en/wbdr

Join us at #WFH2020WorldCongress for the largest congress for the #bleedingdisorders community! While there, take the time to explore the Batu Caves, said to be around 400 million years old. ow.ly/oahV50vbFDR #TreatmentforAll

Bayer Makes Global Impact Through World Federation of Hemophilia Humanitarian Aid Program | BioSpace biospace.com/article/bayer-… #jobs

St. Jude Children’s Research Hospital and the World Federation of Hemophilia announce collaboration New arrangement will establish gene therapy clinical trial for hemophilia patients in low- and middle-income countries stjude.org/media-resource… #genetherapy #WorldHemophiliaDay2019

April 17 is the day!

@DevinNunes You requested money from me. You are a Trump stooge. Ask him for money

We are pleased to announce our acquisition of @Bioverativ, a biopharma company focused on therapies for hemophilia and other rare blood disorders, expanding our presence in specialty care and strengthening our leadership in rare diseases #Bioverativ bit.ly/2rxifEe